Real life small airway outcomes in severe asthma patients receiving biologic therapies

Rory Chan, Chris RuiWen Kuo, Brian Lipworth (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

Abstract

FEF25-75 should be incorporated to assess improvement in small airways dysfunction (SAD) for severe asthma patients receiving biologics. Impulse oscillometry (IOS) can be useful as an adjunct, particularly in those with baseline IOS-defined SAD.
Original languageEnglish
JournalThe Journal of Allergy and Clinical Immunology: In Practice
Early online date2 Feb 2021
DOIs
Publication statusE-pub ahead of print - 2 Feb 2021

Keywords

  • small airways dysfunction
  • severe refractory asthma
  • omalizumab
  • mepolizumab
  • benralizumab
  • impulse oscillometry
  • FEF25-75

Fingerprint Dive into the research topics of 'Real life small airway outcomes in severe asthma patients receiving biologic therapies'. Together they form a unique fingerprint.

Cite this